Sun Pharma Advanced Research Co Ltd (SPARC) Stock Price & News

Why is SPARC up 7.52%?

Dive Deeper

SPARC:NSE

Sun Pharma Advanced Research Co Ltd

₹211.84

+7.52%

(+14.81) 1D

Nov 9, 9:34:29 AM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for SPARC...

Open

₹198.50

High

₹215.39

Low

₹196.50

Mkt. cap

68.75B

Avg. vol.

926.94K

Volume

3.24M

P/E ratio

4.19

52-wk high

₹289.00

52-wk low

₹108.00

EPS

₹50.50

Shares outstanding

255.99M

No. of employees

279

Open

₹198.50

High

₹215.39

Low

₹196.50

Mkt. cap

68.75B

Avg. vol.

926.94K

Volume

3.24M

P/E ratio

4.19

52-wk high

₹289.00

52-wk low

₹108.00

EPS

₹50.50

Shares outstanding

255.99M

No. of employees

279

Related stocks

MOREPENLAB

Morepen Laboratories Ltd

₹99.14

+4.99%

SENORES

Senores Pharmaceuticals Ltd

₹1,213.10

+1.60%

SYNCOMF

Syncom Formulations (India) Ltd

₹20.79

-1.05%

SHUKRAPHAR

Shukra Medtech Limited

₹83.40

+2.23%

News stories

From web sources and news partners

Yahoo Finance

30 minutes ago

Dow, S&P 500, Nasdaq Futures Rebound After Sharp AI Selloff Last Week: NVDA, AMD, VIR, SNDK In Focus

CryptoRank

44 minutes ago

S&P 500 Earnings Beats Shrink to Just 2.7%, Weakest in Four Years Despite 84% of Companies Topping Forecasts

Binance

6 hours ago

TradFi News | Nasdaq Drops 3.4% in Week as AI Chip Stocks Slump; Berkshire Posts Record $9.6 Billion Buyback

BigGo Finance

1 hour ago

Goldman Sachs Panic Index Breaches Extreme 9.5 Threshold; History Shows S&P 500 Averaged 4.6% Gain Over Following Three Months

About Sun Pharma Advanced Research Co Ltd

CEO-

Employees279

Founded2006

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitesparc.life

All values in INR	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	84.50M	18.53B	399.20M	536.50M
Cost of goods sold	72.10M	115.06M	76.60M	99.50M
Cost of revenue	72.10M	115.06M	76.60M	99.50M
Research and development expenses	62.70M	28.44M	132.60M	92.50M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	424.60M	557.37M	448.00M	448.50M
Operating expense	604.50M	605.33M	684.60M	678.90M
Total operating expenses	676.60M	720.39M	761.20M	778.40M
Operating income	-592.10M	17.81B	-362.00M	-241.90M
Other non operating income	-	-116.03M	236.60M	-
EBT including unusual items	-803.50M	17.61B	-206.70M	-243.10M
EBT excluding unusual items	-679.90M	17.61B	-206.70M	-243.10M
Income tax expense	700.00K	-3.84M	1.10M	800.00K
Effective tax rate	-0.09%	-0.02%	-0.53%	-0.33%
Other operating expenses	91.50M	-3.44M	82.00M	115.90M
Net income	-804.20M	17.61B	-207.80M	-243.90M
Net profit margin	-951.72%	95.04%	-52.05%	-45.46%
Earnings per share	-	-	-	-
Interest and investment income	-	102.87M	-	-
Interest expense	-87.80M	-90.07M	-81.30M	-1.20M
Net interest expenses	-87.80M	12.80M	-81.30M	-1.20M
Depreciation and amortization charges	25.70M	22.96M	22.00M	22.00M
EBITDA	-570.75M	17.83B	-342.34M	-219.90M
Gain or loss from assets sale	-	-	-	-

Ask anything